Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 08-2019 | 05-2019 | 11-2018 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 0 | 25,591 |
| Marketable Securities | 0 | 0 | 13,448 |
| Other current assets | 0 | 0 | 1,615 |
| TOTAL | $0 | $0 | $40,654 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 13,093 |
| Other Non-Current Assets | 0 | 0 | 321 |
| TOTAL | $N/A | $N/A | $13,414 |
| Total Assets | $0 | $0 | $45,397 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 0 | 1,297 |
| Accrued Expenses | 0 | 0 | 3,115 |
| Other current liabilities | 0 | 0 | 28,420 |
| TOTAL | $0 | $0 | $32,832 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 0 | 49,412 |
| TOTAL | $N/A | $N/A | $49,412 |
| Total Liabilities | $0 | $0 | $82,244 |
| Shareholders' Equity | |||
| Common Shares | 0 | 0 | 3 |
| Retained earnings | 0 | 0 | -38,757 |
| Other shareholders' equity | 0 | 0 | -4 |
| TOTAL | $0 | $0 | $-36,847 |
| Total Liabilities And Equity | $0 | $0 | $45,397 |